Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack

Boston Scientific has announced that a recent cyberattack is expected to negatively impact its financial performance for 2026. The medical device manufacturer indicated that it is unlikely to meet its previously established sales and profit forecasts as a direct result of the security incident.

The company is currently assessing the extent of the disruption caused by the attack. While the full scope of the financial implications remains under evaluation, the firm has formally adjusted its outlook to reflect the anticipated shortfall in its long-term growth targets.